Compare VLRS & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VLRS | SDGR |
|---|---|---|
| Founded | 2005 | 1990 |
| Country | Mexico | United States |
| Employees | 6901 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 810.5M | 856.7M |
| IPO Year | N/A | 2020 |
| Metric | VLRS | SDGR |
|---|---|---|
| Price | $6.97 | $12.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $9.66 | ★ $21.75 |
| AVG Volume (30 Days) | 936.3K | ★ 1.4M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $255,869,000.00 |
| Revenue This Year | $13.69 | $6.11 |
| Revenue Next Year | $12.54 | $7.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $3.49 | $11.11 |
| 52 Week High | $10.80 | $27.63 |
| Indicator | VLRS | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 28.51 | 44.61 |
| Support Level | $5.99 | $11.11 |
| Resistance Level | $7.27 | $13.36 |
| Average True Range (ATR) | 0.46 | 0.71 |
| MACD | -0.15 | 0.19 |
| Stochastic Oscillator | 15.42 | 57.92 |
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.